# Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

> **NCT06798402** · PHASE2 · RECRUITING · sponsor: **Al-Mustafa University College** · enrollment: 80 (estimated)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** Ciprofloxacin (BAYO9867)
- **DRUG:** sodium stibogluconate (Pentostam)

## Key facts

- **NCT ID:** NCT06798402
- **Lead sponsor:** Al-Mustafa University College
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-07
- **Primary completion:** 2025-11-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2025-09-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06798402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06798402, "Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06798402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*